← Back to Search

Vitamin E

Low tocotrienols group for Osteoporosis

Phase 1 & 2
Waitlist Available
Research Sponsored by Texas Tech University Health Sciences Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after 6 weeks, after 12 weeks
Awards & highlights

Study Summary

This trial is testing whether taking a tocotrienols supplement for 12 weeks can help improve bone health in postmenopausal women.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after 6 weeks, after 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after 6 weeks, after 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Serum bone resorption marker
Secondary outcome measures
Serum bone formation marker
Other outcome measures
Liver function test
Oxidative stress marker
Quality of life Survey
+1 more

Trial Design

3Treatment groups
Active Control
Group I: Low tocotrienols groupActive Control1 Intervention
Low dose of tocotrienols
Group II: High tocotrienols groupActive Control1 Intervention
High dose of tocotrienol
Group III: Placebo groupActive Control1 Intervention
No active dose of tocotrienols

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Texas Tech University Health Sciences CenterLead Sponsor
104 Previous Clinical Trials
10,696 Total Patients Enrolled
1 Trials studying Osteoporosis
171 Patients Enrolled for Osteoporosis
Texas Woman's UniversityOTHER
86 Previous Clinical Trials
5,802 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments being made for this investigation?

"As indicated on clinicaltrials.gov, this trial is not presently enrolling new participants. This study was initially published on February 1st 2014 and the last edit was made on 28th of February 2022. Although it currently is not looking for candidates, 138 other trials are actively recruiting as of now."

Answered by AI
Recent research and studies
BMC Complementary and Alternative MedicineJournal
A 12-week Evaluation of Annatto Tocotrienol Supplementation for Postmenopausal Women: Safety, Quality of Life, Body Composition, Physical Activity, and Nutrient Intake
Shen, Chwan-Li, Shu Wang, Shengping Yang, Michael D. Tomison, Mehrnaz Abbasi, Lei Hao, Sheyenne Scott, et al.. 2018. “A 12-week Evaluation of Annatto Tocotrienol Supplementation for Postmenopausal Women: Safety, Quality of Life, Body Composition, Physical Activity, and Nutrient Intake”. BMC Complementary and Alternative Medicine. Springer Science and Business Media LLC. doi:10.1186/s12906-018-2263-0.
Osteoporosis InternationalJournal
Tocotrienol Supplementation Suppressed Bone Resorption and Oxidative Stress in Postmenopausal Osteopenic Women: A 12-week Randomized Double-blinded Placebo-controlled Trial
Shen, C.-L., S. Yang, M. D. Tomison, A. W. Romero, C. K. Felton, and H. Mo. 2018. “Tocotrienol Supplementation Suppressed Bone Resorption and Oxidative Stress in Postmenopausal Osteopenic Women: A 12-week Randomized Double-blinded Placebo-controlled Trial”. Osteoporosis International. Springer Science and Business Media LLC. doi:10.1007/s00198-017-4356-x.
BMJ OpenJournal
Safety and Efficacy of Tocotrienol Supplementation for Bone Health in Postmenopausal Women: Protocol for a Dose–response Double-blinded Placebo-controlled Randomised Trial
Shen, Chwan-Li, Huanbiao Mo, Shengping Yang, Shu Wang, Carol K Felton, Michael D Tomison, and Ima Nirwana Soelaiman. 2016. “Safety and Efficacy of Tocotrienol Supplementation for Bone Health in Postmenopausal Women: Protocol for a Dose–response Double-blinded Placebo-controlled Randomised Trial”. BMJ Open. BMJ. doi:10.1136/bmjopen-2016-012572.
clinicaltrials.govStudy
Tocotrienols and Bone Health of Postmenopausal Women
2014. "Tocotrienols and Bone Health of Postmenopausal Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02058420.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top